TECHNOLOGY PLATFORM

             Genetically engineered vaccines are the future development trend of human vaccines. As one of the mainstream expression systems of genetically engineered vaccines, the baculovirus-insect cell expression vector system (BEVS) has shown great advantages.

       SCVC is the first vaccine R&D enterprise to send BEVS system for inspection in China. At present, all the testing standards of the system have been established. The company has fully grasped the initiative in the construction of vector, cell culture, process enlargement and culture medium.

    SCVC fill a gap in this field:

    There are no BEVS based vaccine manufacturers and products in China!